Glaucoma device tested against standard laser therapy
NCT ID NCT02928289
Summary
This study tested a new medical device called the VISCO360 System against a standard laser treatment (SLT) for lowering eye pressure in adults with open-angle glaucoma. Participants had mild to moderate glaucoma and had previously undergone cataract surgery. The trial was terminated early after enrolling 29 people and aimed to follow them for two years to compare safety and effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN-ANGLE GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Coastal Vision Medical Group
Orange, California, 92868, United States
-
Dean McGee Eye Institute
Oklahoma City, Oklahoma, 73104, United States
-
El Paso Eye Surgeons
El Paso, Texas, 79902, United States
-
Ophthalmology Associates
Fort Worth, Texas, 76102, United States
-
Vold Vision
Fayetteville, Arkansas, 72704, United States
-
Wills Eye Hospital
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.